Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial

(2014) Nita Bhandari et al.   LANCET

Circulating human rotavirus specific CD4 T cells identified with a class II tetramer express the intestinal homing receptors α4β7 and CCR9

(2014) Miguel Parra et al.   VIROLOGY

A Systematic Review of Anti-Rotavirus Serum IgA Antibody Titer as a Potential Correlate of Rotavirus Vaccine Efficacy

(2013) Manish Patel et al.   JOURNAL OF INFECTIOUS DISEASES

The VP8* Domain of Neonatal Rotavirus Strain G10P[11] Binds to Type II Precursor Glycans

(2013) S. Ramani et al.   JOURNAL OF VIROLOGY

Poly-LacNAc as an Age-Specific Ligand for Rotavirus P[11] in Neonates and Infants

(2013) Yang Liu et al.   PLoS One

Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine

(2013) Daniel Herrera et al.   Human Vaccines & Immunotherapeutics

Correlates of protection to influenza virus, where do we go from here?

(2013) Rebecca Cox   Human Vaccines & Immunotherapeutics

Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis

(2013) Brigitte Cheuvart et al.   Human Vaccines & Immunotherapeutics

Nomenclature for Immune Correlates of Protection After Vaccination

(2012) S. A. Plotkin et al.   CLINICAL INFECTIOUS DISEASES

A time-resolved immunoassay to measure serum antibodies to the rotavirus VP6 capsid protein

(2012) Owen Kavanagh et al.   JOURNAL OF VIROLOGICAL METHODS

Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen

(2012) Liya Hu et al.   NATURE

Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines

(2012) Manish Patel et al.   VACCINE

Immunogenicity of the pentavalent rotavirus vaccine in African infants

(2012) George E. Armah et al.   VACCINE

Rotavirus immune responses and correlates of protection

(2012) Juana Angel et al.   Current Opinion in Virology

Efficacy Studies of Influenza Vaccines: Effect of End Points Used and Characteristics of Vaccine Failures

(2011) Joshua G. Petrie et al.   JOURNAL OF INFECTIOUS DISEASES

2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis

(2011) Jacqueline E Tate et al.   LANCET INFECTIOUS DISEASES

Human Rotavirus Vaccine Is Highly Efficacious When Coadministered With Routine Expanded Program of Immunization Vaccines Including Oral Poliovirus Vaccine in Latin America

(2011) Miguel W. Tregnaghi et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children

(2011) Steven Black et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Influence of Potential Protective Mechanisms on the Development of Live Rotavirus Vaccines

(2010) Richard L. Ward et al.   JOURNAL OF INFECTIOUS DISEASES

Serological Correlate of Protection against Norovirus‐Induced Gastroenteritis

(2010) Amanda Reeck et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

(2010) K Zaman et al.   LANCET

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

(2010) George E Armah et al.   LANCET

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

(2010) Shabir A. Madhi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Maternal antibodies to rotavirus: Could they interfere with live rotavirus vaccines in developing countries?

(2010) J. Chan et al.   VACCINE

Resistance to Rotavirus Infection in Adult Volunteers Challenged with a Virulent G1P1A[8] Virus Correlated with Serum Immunoglobulin G Antibodies to Homotypic Viral Proteins 7 and 4

(2009) Lijuan Yuan et al.   JOURNAL OF INFECTIOUS DISEASES

Mechanisms of Protection Against Rotavirus Infection and Disease

(2009) Richard Ward   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

(2008) Alexandre C Linhares et al.   LANCET

Concomitant Use of the Oral Pentavalent Human-Bovine Reassortant Rotavirus Vaccine and Oral Poliovirus Vaccine

(2008) Max Ciarlet et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007

(2008) Maryna Eichelberger et al.   VACCINE

Evaluating a surrogate endpoint at three levels, with application to vaccine development

(2007) Peter B. Gilbert et al.   STATISTICS IN MEDICINE